•  
• Tweet
•  
•  
•        Print
•  
•        Email
•  
•         Track Keywords

"The possibility that the US Senate might pass a tax bill rallied domestic equity markets," says Sol Waksman, founder and president of BarclayHedge. "For each of the past 13 months, the monthly close of the S&P 500 has set a new record high."

Once again, the Technology Index powered upward with a 3.63% return in November. Technology has had 12 months of gains in the past 13 months, and is now up 25.29% for the year.

The Healthcare and Biotechnology Index bounced back from a 1.57% loss in October with a 2.98% gain in November. Equity Long Bias was up 1.63%, Emerging Markets added 0.64%, Distressed Securities were up 0.59%, and Pacific Rim Equities rose 0.33%.

Eight hedge fund indices lost ground in November. The Merger Arbitrage Index was down 0.79%, European Equities gave up 0.57%, Fixed Income Arbitrage lost 0.30%, and Convertible Arbitrage slid 0.21%.

All of Barclay's 17 hedge fund indices are profitable after eleven months. Following the strong performance of the Technology Index, Healthcare & Biotechnology is up 18.70% for the year, Emerging Markets have gained 16.40%, Pacific Rim Equities are up 13.18%, and the Equity Long Bias Index has added 12.67%.

The Barclay Fund of Funds Index lost 0.03% in November, but is up 5.66% for the year.